… Glucocorticoids are the mainstay of treatment for autoimmune blistering diseases (AIBDs).
The Glucocorticoid Toxicity Index (GTI) is a novel, outcome-based …

… Rituximab and oral corticosteroid therapy are safe and effective when used as first-line
treatments for pemphigus patients, according to additional research. Cho and colleagues …

… In pooled meta-analysis, autoimmune blistering disease patients … corticosteroid treatment
results in increased cardiovascular-related adverse events in autoimmune blistering disease…

… of autoimmune blistering diseases, including bullous … that in severe disease, systemic
corticosteroid use should be … , they recommend adjuvant use of topical corticosteroids all over …

… of EBA from other pemphigoid diseases, given that it shows … , while all other pemphigoid
diseases present with an n-… is used in combination with systemic glucocorticoids (1 mg/kg …

… last five years, she took prednisone continuously. In October 2019, she was admitted to our
outpatient clinic for the persistence of AD despite therapy with prednisone. The patient began …

… Bullous pemphigoid (BP) is a severe autoimmune blistering … variant of the pemphigoid
diseases. It manifests as exquisitely … serious side effects with corticosteroid therapy. The known …

… following cessation of the BA or systemic corticosteroids used to treat the AIBD. Five cases
rechallenged the patient with the involved BA and four of the five reported recurrence, often …

… This review includes a total of 1685 patients with autoimmune blistering diseases, of
whom 781 had bullous pemphigoid and 904 had either pemphigus vulgaris or pemphigus …

… autoimmune bullous diseases triggered by the COVID-19 vaccine. Clinical and histopathological
examinations confirmed the diagnosis of bullous pemphigoid (… corticosteroid therapy at …